Tracked shipping to New Zealand with premium packaging for just NZ$15 

Ship to
New Zealand
0

My Account

  • argentina
  • chile
  • colombia
  • españa
  • méxico
  • perú
  • estados unidos
  • internacional

menu

Select your country

Americas

Europe

Rest of the world

portada Adjuvant Therapy of Primary Breast Cancer vi (Recent Results in Cancer Research, 152)
Type
Physical Book
Publisher
Author
Language
English
Pages
522
Format
Paperback
ISBN13
9783642457715
Edition No.
1

Adjuvant Therapy of Primary Breast Cancer vi (Recent Results in Cancer Research, 152)

Senn Hans-Jörg,Gelber Richard D.,Goldhirsch Aron (Author) · Springer · Paperback

Adjuvant Therapy of Primary Breast Cancer vi (Recent Results in Cancer Research, 152) - Senn Hans-Jörg,Gelber Richard D.,Goldhirsch Aron

Cheaper New Book Imported to New Zealand
Delivery: 14 Aug - 24 Aug Shipping: 12 to 14 business days.
NZ$ 119.14
Faster New Book Imported to New Zealand
Delivery: 04 Aug - 11 Aug Shipping: 4 to 5 business days.
NZ$ 220.83
Import costs and 15% GST included in the price ✅
NZ$ 119.14

Choose the list to add your product or create one New List

Go to My Wishlists
Calculate shipping cost

Synopsis "Adjuvant Therapy of Primary Breast Cancer vi (Recent Results in Cancer Research, 152)"

This RRCR-conference-volume marks "number six" in a 20-year evolution of international conferences on the adjuvant therapy of primary breast cancer. Starting in 1978, a handful of some 80 en- thusiastic breast cancer surgeons and oncologists, met in a se- cluded mountain resort near st. Gallen in Eastern Switzerland, to exchange their early data of some pioneer trials on adjuvant sys- temic therapy of early breast cancer, and to correlate their future research efforts to overcome the frustrating prognostic stagna- tion of this dominant neoplastic disease in Western females dur- ing the past decades. Repeated every 3-4 years, these St. Gallen International Conferences on Adjuvant Therapy of Primary Breast Cancer have continuously grown in numbers of partici- pants and in normative, therapeutic influence by being published in major oncology journals [1-3], the last (6th) conference hav- ing taken place from February 25-28, 1998 with more than 1800 attendees from over 50 countries worldwide. What is the fascination of adjuvant therapy in primary (early) breast cancer, and what has changed, during the last 3 years since March 1995, to justify another international gathering of this size, and of the world's leading experts in the field? There is no question, that providing even more effective care and designing appropriate recommendations for the multitudes of patients with so-called early breast cancer or at high risk of developing the disease, remain highly important public health goals.

Customers reviews

More customer reviews
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)

Frequently Asked Questions about the Book

Is the book original?

All books in our catalog are Original.

In what language is the book written?

The book is written in English.

What is the format of this book?

The binding of this edition is Paperback.

Questions and Answers about the Book

Do you have a question about the book? Login to be able to add your own question.

Opinions about Bookdelivery

More customer reviews